Oral dosage form containing nitisinone for managing hereditary tyrosinemia type 1. Manufactured by pharmaceutical companies and supplied to hospitals, specialty pharmacies, and rare disease treatment centers. Procured by healthcare providers for pediatric and adult patients in clinical settings worldwide.